AVXL

ANAVEX LIFE SCIENCES CORP.

Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer

Total Trades

7

Buys

1

Sells

3

Largest Trade

$1M+

Insiders

3

Institutional Funds

153

Inst. Value

$1M+

Activist Filings

4

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Donhauser Peter D.O.DirectorBUY$1K–$15K3K$3.64Jun 17, 2024
MISSLING CHRISTOPHER UPresident and CEOSELL$100K–$500K73K$5.11Apr 1, 2024
MISSLING CHRISTOPHER UPresident and CEOEXERCISE$50K–$100K73K$1.32Apr 1, 2024
MISSLING CHRISTOPHER UPresident and CEOSELL$1M+268K$7.98Jul 1, 2023
MISSLING CHRISTOPHER UPresident and CEOEXERCISE$500K+500K$1.60Jul 1, 2023
Skarpelos AthanasiosDirectorEXERCISE$15K–$50K50K$0.92May 28, 2022
Skarpelos AthanasiosDirectorSELL$100K–$500K50K$9.06May 28, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 153 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

The Vanguard Group - 23-1945930

SC 13G/A · Feb 13, 2024

5.3%

4.4M shares

BlackRock, Inc.

SC 13G/A · Jan 25, 2024

8.1%

6.7M shares

BlackRock, Inc.

SC 13G/A · Jan 31, 2023

7.2%

5.6M shares

View on Google Finance →